Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Diabetes Care. 2012 Nov;35(11):2390-2. doi: 10.2337/dc12-0464. Epub 2012 Aug 8.

    Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT).

    Source

    Phoenix VA Health Care System, Phoenix, AZ, USA. aramesh.saremi@va.gov

    Abstract

    OBJECTIVE:

    To determine the effect of statin use on progression of vascular calcification in type 2 diabetes (T2DM).

    RESEARCH DESIGN AND METHODS:

    Progression of coronary artery calcification (CAC) and abdominal aortic artery calcification (AAC) was assessed according to the frequency of statin use in 197 participants with T2DM.

    RESULTS:

    After adjustment for baseline CAC and other confounders, progression of CAC was significantly higher in more frequent statin users than in less frequent users (mean ± SE, 8.2 ± 0.5 mm(3) vs. 4.2 ± 1.1 mm(3); P < 0.01). AAC progression was in general not significantly increased with more frequent statin use; in a subgroup of participants initially not receiving statins, however, progression of both CAC and AAC was significantly increased in frequent statin users.

    CONCLUSIONS:

    More frequent statin use is associated with accelerated CAC in T2DM patients with advanced atherosclerosis.

    PMID:
    22875226
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3476911
    [Available on 2013/11/1]

      Supplemental Content

      Icon for HighWire

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk